Abiopharma

Clinical trial NCT04864054: enrollment: 20 → 60 participants.

Clinical trial NCT06745583: collaborators removed: Elixiron Immunotherpeutics Inc..

Clinical trial NCT03737643 updates: 1. completion date: 2028-03-30 → 2026-12-23 2. primary completion date: 2025-03-28 → 2025-03-17 3. collaborators added: GOG Foundation 4. collaborators removed: GOG Foundation, Inc. (GOG Foundation)

Clinical trial NCT07357415: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07146230 updates: 1. start date: 2026-03-01 → 2026-09-01 2. completion date: 2028-08-01 → 2029-02-01 3. primary completion date: 2027-10-01 → 2028-04-01

Clinical trial NCT05704829 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2029-06-01 → 2030-09-01 3. primary completion date: 2025-06-18 → 2030-06-01 4. enrollment: 402 → 702 participants

Clinical trial NCT05002959 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-12-01 → 2026-03-05 3. primary completion date: 2026-10-01 → 2026-03-05

Clinical trial NCT07224165 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-06-04 3. completion date: 2027-06-01 → 2027-07-01 4. primary completion date: 2027-04-01 → 2027-05-01

Clinical trial NCT07040319: start date: 2026-05-31 → 2026-06-30.

Clinical trial NCT05690841 updates: 1. collaborators added: Medicines for Malaria Venture, Universidad Peruana Cayetano Heredia, GlaxoSmithKline 2. collaborators removed: Universidad Peruana Cayetano Heredia- subcontractor to UCSF as local Sponsor